Technical Analysis for BPTH - Bio-Path Holdings Inc

Grade Last Price % Change Price Change
grade F 4.94 -0.60% -0.03
BPTH closed down 0.6 percent on Tuesday, July 14, 2020, on 74 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BPTH trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -0.60%
Bollinger Band Squeeze Range Contraction -0.60%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Biotechnology Solid Tumors Breast Cancer Lymphoma Cell Biology Therapeutic Products Oncogenes Apoptosis Blood Cancers

Is BPTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.79
52 Week Low 2.9203
Average Volume 86,488
200-Day Moving Average 6.81
50-Day Moving Average 5.21
20-Day Moving Average 5.09
10-Day Moving Average 5.09
Average True Range 0.29
ADX 15.95
+DI 17.08
-DI 16.19
Chandelier Exit (Long, 3 ATRs ) 4.68
Chandelier Exit (Short, 3 ATRs ) 5.67
Upper Bollinger Band 5.24
Lower Bollinger Band 4.93
Percent B (%b) 0.02
BandWidth 6.10
MACD Line -0.06
MACD Signal Line -0.05
MACD Histogram -0.0091
Fundamentals Value
Market Cap 494.24 Million
Num Shares 100 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -70.57
Price-to-Sales 3232.58
Price-to-Book 4.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.17
Resistance 3 (R3) 5.15 5.05 5.13
Resistance 2 (R2) 5.05 4.99 5.06 5.12
Resistance 1 (R1) 5.00 4.96 5.02 5.02 5.11
Pivot Point 4.90 4.90 4.91 4.91 4.90
Support 1 (S1) 4.84 4.84 4.86 4.86 4.77
Support 2 (S2) 4.74 4.80 4.75 4.76
Support 3 (S3) 4.69 4.74 4.75
Support 4 (S4) 4.71